These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 743977
1. Evidence of a small molecule in mouse Leydig cell tumors which inhibits the conversion of estrogen receptor from 4S to 5S. Sato B, Huseby RA, Samuels LT. Endocrinology; 1978 Feb; 102(2):545-55. PubMed ID: 743977 [Abstract] [Full Text] [Related]
2. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors. Sato B, Spomer W, Huseby RA, Samuels LT. Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739 [Abstract] [Full Text] [Related]
3. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor. Maeda Y, Sato B, Noma K, Kishimoto S, Koizumi K, Aono T, Matsumoto K. Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850 [Abstract] [Full Text] [Related]
7. Estrogen binding component of mouse Leydig cell tumor: an in vitro conversion from nonreceptor to receptor-like molecule. Sato B, Maeda Y, Noma K, Matsumoto K, Yamamura Y. Endocrinology; 1981 Feb; 108(2):612-9. PubMed ID: 7449741 [No Abstract] [Full Text] [Related]
8. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization. Müller RE, Traish AM, Hirota T, Bercel E, Wotiz HH. Endocrinology; 1985 Jan; 116(1):337-45. PubMed ID: 2981069 [Abstract] [Full Text] [Related]
9. Properties of the estrogen receptor in the human oviduct and its interaction with ethinylestradiol and mestranol in vitro. Muechler EK, Kohler D. J Clin Endocrinol Metab; 1980 Nov; 51(5):962-7. PubMed ID: 7419693 [Abstract] [Full Text] [Related]
10. [Estrogen receptor in human endometrium--energy requirement, stability and subunit structure-- (author's transl)]. Ozaki M, Kurachi K. Nihon Naibunpi Gakkai Zasshi; 1976 Aug 20; 52(8):774-83. PubMed ID: 1035170 [Abstract] [Full Text] [Related]
11. Biological and biochemical characterization of estrogen-dependent mouse Leydig cell tumors. Sato B, Miyashita Y, Nishizawa Y, Noma K, Kishimoto S, Mori H, Matsumoto K. J Steroid Biochem; 1987 Aug 20; 27(1-3):421-9. PubMed ID: 3695489 [Abstract] [Full Text] [Related]
12. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors. Navickis RJ, Shimkin MB, Hsueh AJ. Cancer Res; 1981 May 20; 41(5):1646-51. PubMed ID: 6260347 [Abstract] [Full Text] [Related]
13. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form. Nishizawa Y, Maeda Y, Noma K, Sato B, Matsumoto K, Yamamura Y. Endocrinology; 1981 Nov 20; 109(5):1463-72. PubMed ID: 6795027 [Abstract] [Full Text] [Related]
14. Estriol and estradiol interactions with the estrogen receptor in vivo and in vitro. Müller RE, Beebe DM, Bercel E, Traish AM, Wotiz HH. J Steroid Biochem; 1984 Apr 20; 20(4B):1039-46. PubMed ID: 6727349 [Abstract] [Full Text] [Related]
15. A high-affinity estrogen-binding protein in rat placental trophoblast. McCormack SA, Glasser SR. Endocrinology; 1976 Sep 20; 99(3):701-12. PubMed ID: 182465 [Abstract] [Full Text] [Related]